Atlas Trials

Subcutaneous (SC) Bortezomib-Regimens for Patients With RR MM Failing Prior IV Bortezomib-Containing Regimens

Clinical trial NCT01695330 · TERMINATED

Trial details

NCT number
NCT01695330
Sponsor
Oncotherapeutics
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Multiple Myeloma
Start date
2012-05-01
Primary completion
2015-10-01
Enrollment
5

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.